APTO
Aptose Biosciences, Inc.
APTO
APTO
Delisted
APTO was delisted on the 1st of April, 2025.
58 hedge funds and large institutions have $227M invested in Aptose Biosciences, Inc. in 2020 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 19 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
16% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 19
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
58
Holding in Top 10
4
Calls
$507K
Puts
$203K
Top Buyers
| 1 | +$8.13M | |
| 2 | +$7.41M | |
| 3 | +$4.94M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$4.73M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$3.44M |
Top Sellers
| 1 | -$12.1M | |
| 2 | -$5.63M | |
| 3 | -$4.02M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$2.03M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.56M |